Robert E Abernathy's Net Worth
$49.1 Million
Who is Robert E Abernathy?
Robert E Abernathy has an estimated net worth of $49.1 Million. This is based on reported shares across multiple companies, which include RADIOSHACK CORP, AVIENT CORP, Halyard Health, Inc., HAEMONETICS CORP, LUBRIZOL Corp, and KIMBERLY CLARK CORP.
SEC CIK
Robert E Abernathy's CIK is 0001222888
Past Insider Trading and Trends
2012 was Robert E Abernathy's most active year for acquiring shares with 20 total transactions. Robert E Abernathy's most active month to acquire stocks was the month of March. 2009 was Robert E Abernathy's most active year for disposing of shares, totalling 20 transactions. Robert E Abernathy's most active month to dispose stocks was the month of March. 2011 saw Robert E Abernathy paying a total of $10,107,555.96 for 260,938.881 shares, this is the most they've acquired in one year. In 2011 Robert E Abernathy cashed out on 395,943 shares for a total of $12,626,074.93, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RADIOSHACK CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| +100.00% | 100K |
$2.55 | $255,010.60 | 200K |
Aug 2 - Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
∞
| 100K |
$2.53 | $253,000.00 | 100K |
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVIENT CORP (AVNT) Snapshot price: $36.08
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.47% | 806 |
—
|
—
| 33.4K |
Jun 28
| |||
Form 4
| +2.54% | 808 |
—
|
—
| 32.59K |
Mar 29
| |||
Form 4
| +2.69% | 834 |
—
|
—
| 31.78K |
Dec 29
| |||
Form 4
| +3.28% | 984 |
—
|
—
| 30.95K |
Sep 29
| |||
Form 4
| +2.97% | 863 |
—
|
—
| 29.96K |
Jun 30
| |||
Form 4
| +3.03% | 857 |
—
|
—
| 29.1K |
Mar 31
| |||
Form 4
| +3.82% | 1.04K |
—
|
—
| 28.24K |
Dec 31
| |||
Form 4
| +4.37% | 1.14K |
—
|
—
| 27.2K |
Sep 30
| |||
Form 4
| +3.49% | 880 |
—
|
—
| 26.07K |
Jun 30
| |||
Form 4
| +2.93% | 717 |
—
|
—
| 25.18K |
Mar 31
| |||
Form 4
| +2.63% | 627 |
—
|
—
| 24.47K |
Dec 31
| |||
Form 4
| +3.22% | 744 |
—
|
—
| 23.84K |
Sep 30
| |||
Form 4
| +2.98% | 669 |
—
|
—
| 23.1K |
Jun 30
| |||
Form 4
| +3.14% | 682 |
—
|
—
| 22.43K |
Mar 31
| |||
Form 4
| +3.84% | 804 |
—
|
—
| 21.75K |
Dec 31
| |||
Form 4
| +6.09% | 1.2K |
—
|
—
| 20.94K |
Sep 30
| |||
Form 4
| +6.76% | 1.25K |
—
|
—
| 19.74K |
Jun 30
| |||
Form 4
| +10.16% | 1.71K |
—
|
—
| 18.49K |
Mar 31
| |||
Form 4
| +5.53% | 879 |
—
|
—
| 16.79K |
Dec 31
| |||
Form 4
| +6.72% | 1K |
—
|
—
| 15.91K |
Sep 30
| |||
Form 4
| +7.62% | 1.05K |
—
|
—
| 14.9K |
Jun 30
| |||
Form 4
| +8.70% | 1.11K |
—
|
—
| 13.85K |
Mar 31
| |||
Form 4
| +9.91% | 1.15K |
—
|
—
| 12.74K |
Dec 31
| |||
Form 4
| +627.75% | 10K |
$30.64 | $306,422.00 | 11.59K |
Oct 25
| |||
Form 4
| +87.85% | 745 |
—
|
—
| 1.59K |
Sep 30
| |||
Form 4
| +351.06% | 660 |
—
|
—
| 848 |
Jun 30
| |||
Form 4
|
∞
| 188 |
—
|
—
| 188 |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Halyard Health, Inc. (AVNS) Snapshot price: $18.97
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
| -22.95% | -18.37K |
$39.50 | -$725,457.00 | 61.68K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
| +14.28% | 10K |
$31.06 | $310,600.00 | 80.04K |
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
| +603.10% | 60.08K |
—
|
—
| 70.04K |
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HAEMONETICS CORP (HAE) Snapshot price: $77.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.47% | 2.23K |
—
|
—
| 20.08K |
Aug 4
| |||
Form 4
| +18.05% | 2.73K |
—
|
—
| 17.86K |
Aug 5
| |||
Form 4
| +25.54% | 3.08K |
—
|
—
| 15.13K |
Aug 6
| |||
Form 4
| +49.70% | 4K |
$80.93 | $323,720.00 | 12.05K |
Aug 11
| |||
Form 4
| +32.70% | 1.98K |
—
|
—
| 8.05K |
Jul 21
| |||
Form 4
| +31.70% | 1.46K |
—
|
—
| 6.07K |
Jul 24
| |||
Form 4
| +58.30% | 1.7K |
—
|
—
| 4.61K |
Jul 26
| |||
Form 4
|
∞
| 2.91K |
$45.30 | $131,763.16 | 2.91K |
Oct 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LUBRIZOL Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.84% | 1.27K |
—
|
—
| 4.91K |
Apr 28
| |||
Form 4/A
| +142.00% | 1.42K |
$42.27 | $60,016.30 | 2.42K |
Apr 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||